Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Lumexa Imaging Holdings, Inc. (Nasdaq: LMRI) operates the second-largest outpatient imaging center network in the United States, providing diagnostic imaging services through 184 centers across 13 states, including 85 joint ventures with health systems as of September 30, 2025. The company offers advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) scans; basic diagnostic services including X-rays, ultrasounds, and mammograms; and operates via wholly owned centers, variable interest entities, and joint ventures, generating management fees from unconsolidated affiliates. Lumexa Imaging utilizes a scalable integrated technology platform with third-party AI solutions to enhance efficiency and clinical quality, serving a diversified referral network of approximately 100,000 physicians across 29,000 practices, with centers featuring convenient retail settings and extended hours. Founded in 2018 through a partnership between Charlotte Radiology and private equity firm Welsh, Carson, Anderson & Stowe, Lumexa Imaging is headquartered in Raleigh, North Carolina. The company has rapidly expanded from 20 centers in 2018 to its current footprint via 20 acquisitions and 41 de novo openings, targeting high-growth metropolitan areas with favorable demographics. It employs over 5,000 team members and a network of more than 1,000 subspecialized radiologists, performing over 4 million outpatient studies annually. In recent developments, Lumexa Imaging completed its initial public offering on December 10, 2025, pricing 25 million shares at $18.50 to raise $462.5 million, with proceeds primarily allocated to repay a portion of its $1.2 billion term loan debt. Effective July 8, 2025, its affiliate US Radiology Specialists Holdings, LLC rebranded to Lumexa Imaging Equity Holdco, LLC, aligning with the company's unified identity. These moves support ongoing growth in the diagnostic imaging sector, where 58% of consolidated revenue derives from commercial payors.
Company News
BlackRock Inc. Takes $15.77 Million Position in Lumexa Imaging Holdings, Inc. $LMRI
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
Wall Street Analysts See a 36.88% Upside in Lumexa (LMRI): Can the Stock Really Move This High?
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
Lumexa Imaging Q2 Earnings Call Highlights
Lumexa Imaging Announces Second Quarter 2026 Results
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet
Wall Street Analysts Believe Lumexa (LMRI) Could Rally 73.25%: Here's is How to Trade
Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York
Lumexa Imaging Holdings, Inc. (LMRI) Q1 2026 Earnings Call Transcript
Lumexa Imaging Q1 Earnings Call Highlights
Lumexa Imaging Announces First Quarter 2026 Results
Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer
Lumexa Imaging Holdings, Inc. (LMRI) Q4 2025 Earnings Call Transcript
Lumexa Imaging: Clearer Growth Path Ahead
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses